OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 55 citing articles:

Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies
Adam Strzelczyk, Susanne Schubert‐Bast
CNS Drugs (2022) Vol. 36, Iss. 10, pp. 1079-1111
Open Access | Times Cited: 95

New epilepsy therapies in development
Pavel Klein, Rafal M. Kaminski, Matthias J. Koepp, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 9, pp. 682-708
Closed Access | Times Cited: 37

Developmental and epileptic encephalopathies
Ingrid E. Scheffer, Sameer M. Zuberi, Heather C. Mefford, et al.
Nature Reviews Disease Primers (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 21

Dravet syndrome: A systematic literature review of the illness burden
Adam Strzelczyk, Lieven Lagae, Jo M. Wilmshurst, et al.
Epilepsia Open (2023) Vol. 8, Iss. 4, pp. 1256-1270
Open Access | Times Cited: 33

The burden of illness in Lennox–Gastaut syndrome: a systematic literature review
Adam Strzelczyk, Sameer M. Zuberi, Pasquale Striano, et al.
Orphanet Journal of Rare Diseases (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 32

Pharmacotherapy for Dravet Syndrome: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
Simona Lattanzi, Eugen Trinka, Emilio Russo, et al.
Drugs (2023) Vol. 83, Iss. 15, pp. 1409-1424
Open Access | Times Cited: 26

Pathophysiology to Risk Factor and Therapeutics to Treatment Strategies on Epilepsy
Ana Paula de Araújo Boleti, Pedro Henrique de Oliveira Cardoso, Breno Emanuel Farias Frihling, et al.
Brain Sciences (2024) Vol. 14, Iss. 1, pp. 71-71
Open Access | Times Cited: 17

Current state of the epilepsy drug and device pipeline
Samuel W. Terman, Laura Kirkpatrick, Lisa F. Akiyama, et al.
Epilepsia (2024) Vol. 65, Iss. 4, pp. 833-845
Open Access | Times Cited: 15

Development and refinement of the Clinical Global Impression of Improvement for Non-seizure Symptoms measure in Dravet syndrome and Lennox-Gastaut syndrome
J. Scott Andrews, Drishti Shah, Alise Nacson, et al.
Journal of Patient-Reported Outcomes (2025) Vol. 9, Iss. 1
Open Access | Times Cited: 1

Epilepsy in Dravet Syndrome—Current and Future Therapeutic Opportunities
Chao Gao, Mikolaj Pielas, Fuyong Jiao, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 7, pp. 2532-2532
Open Access | Times Cited: 20

The expanding field of genetic developmental and epileptic encephalopathies: current understanding and future perspectives
Nicola Specchio, Marina Trivisano, Eleonora Aronica, et al.
The Lancet Child & Adolescent Health (2024) Vol. 8, Iss. 11, pp. 821-834
Closed Access | Times Cited: 7

Refining management strategies for Lennox–Gastaut syndrome: Updated algorithms and practical approaches
Stéphane Auvin, Alexis Arzimanoglou, Mercé Falip, et al.
Epilepsia Open (2024) Vol. 10, Iss. 1, pp. 85-106
Open Access | Times Cited: 7

Genetic Testing in Children with Developmental and Epileptic Encephalopathies: A Review of Advances in Epilepsy Genomics
Yu‐Tzu Chang, Syuan‐Yu Hong, Wei‐De Lin, et al.
Children (2023) Vol. 10, Iss. 3, pp. 556-556
Open Access | Times Cited: 16

Genetic Background of Epilepsy and Antiepileptic Treatments
Kinga K. Borowicz-Reutt, Julia Czernia, Marlena Krawczyk
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16280-16280
Open Access | Times Cited: 16

Efficacy and safety of six new antiseizure medications for adjunctive treatment of focal epilepsy and epileptic syndrome: A systematic review and network meta-analysis
Jingyi Tong, Tingting Ji, Ting Liu, et al.
Epilepsy & Behavior (2024) Vol. 152, pp. 109653-109653
Closed Access | Times Cited: 6

Efficacy of pharmacological treatments for Dravet syndrome: Systematic review and network meta-analysis
Dujiang Xia, Peng Zhang, Yankun Chen, et al.
Seizure (2024) Vol. 117, pp. 90-97
Closed Access | Times Cited: 6

The potential of CYP46A1 as a novel therapeutic target for neurological disorders: An updated review of mechanisms
Mohaddeseh Sadat Alavi, Gholamreza Karimi, Hussein A. Ghanimi, et al.
European Journal of Pharmacology (2023) Vol. 949, pp. 175726-175726
Closed Access | Times Cited: 13

Clinical trials for Lennox–Gastaut syndrome: Challenges and priorities
Juliet K. Knowles, Aaron E. L. Warren, Ismail Mohamed, et al.
Annals of Clinical and Translational Neurology (2024) Vol. 11, Iss. 11, pp. 2818-2835
Open Access | Times Cited: 4

A review of the putative antiseizure and antiepileptogenic mechanisms of action for soticlestat
Shinichi Kondo, Venkatesha Murthy, Mahnaz Asgharnejad, et al.
Epilepsia (2025)
Open Access

Interictal paroxysmal fast activity and functional connectivity in steroid responsive and non-responsive Lennox-Gastaut syndrome
Zongpu Zhou, Pan Gong, Xianru Jiao, et al.
European Journal of Paediatric Neurology (2025) Vol. 55, pp. 38-46
Closed Access

Page 1 - Next Page

Scroll to top